Ark Invest Sells 5,440 Brera Holdings Shares, Buys 254,600 ATAI Life Sciences Shares
ByAinvest
Monday, Oct 6, 2025 10:53 pm ET1min read
ATAI--
The sale of Brera Holdings shares comes after the company experienced a significant rally last month following the announcement of its Solana Treasury strategy. Brera is set to rebrand as Solmate after an oversubscribed $300 million private equity investment in a public equity offering [1]. Ark Invest initially acquired 6,500,001 shares of Brera for nearly $162 million earlier in September [1].
Meanwhile, Ark Invest's purchase of ATAI Life Sciences shares aligns with the company's focus on Bitcoin and other cryptocurrencies. ATAI Life Sciences is a Bitcoin vault company that allows investors to gain exposure to Bitcoin without directly holding the cryptocurrency. The company's stock has been performing well, with Ark Invest's purchase indicating confidence in its future prospects.
These moves by Ark Invest reflect the firm's strategy to diversify its holdings across various sectors, including technology, healthcare, and cryptocurrencies. The firm's ARKK fund, which focuses on innovation and technology, has seen significant growth in recent years, driven by its investments in companies like Alibaba and Baidu [1].
SLMT--
BTC--
ARK--
Ark Invest has sold approximately 5,440 shares of SOL vault company Brera Holdings and bought approximately 254,600 shares of Bitcoin vault company ATAI Life Sciences on October 6. The sales and purchases were made through the ARKK and ARKG funds.
Ark Invest, led by Cathie Wood, has made significant moves in the financial markets recently. On October 6, the investment firm sold approximately 5,440 shares of Solana vault company Brera Holdings and purchased approximately 254,600 shares of Bitcoin vault company ATAI Life Sciences. These transactions were executed through the ARKK and ARKG funds, respectively.The sale of Brera Holdings shares comes after the company experienced a significant rally last month following the announcement of its Solana Treasury strategy. Brera is set to rebrand as Solmate after an oversubscribed $300 million private equity investment in a public equity offering [1]. Ark Invest initially acquired 6,500,001 shares of Brera for nearly $162 million earlier in September [1].
Meanwhile, Ark Invest's purchase of ATAI Life Sciences shares aligns with the company's focus on Bitcoin and other cryptocurrencies. ATAI Life Sciences is a Bitcoin vault company that allows investors to gain exposure to Bitcoin without directly holding the cryptocurrency. The company's stock has been performing well, with Ark Invest's purchase indicating confidence in its future prospects.
These moves by Ark Invest reflect the firm's strategy to diversify its holdings across various sectors, including technology, healthcare, and cryptocurrencies. The firm's ARKK fund, which focuses on innovation and technology, has seen significant growth in recent years, driven by its investments in companies like Alibaba and Baidu [1].

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet